141 related articles for article (PubMed ID: 25973029)
21. The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats.
Lu J; Jiang T; Wu L; Gao L; Wang Y; Zhou F; Zhang S; Zhang Y
Neuropeptides; 2013 Oct; 47(5):289-95. PubMed ID: 24090950
[TBL] [Abstract][Full Text] [Related]
22. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
23. Myocardial infarction increases ACE2 expression in rat and humans.
Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
[TBL] [Abstract][Full Text] [Related]
24. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules.
Li N; Zimpelmann J; Cheng K; Wilkins JA; Burns KD
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F353-62. PubMed ID: 15467007
[TBL] [Abstract][Full Text] [Related]
25. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
26. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Kanda T; Itoh H
Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-(1-7) inhibits vascular calcification in rats.
Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
[TBL] [Abstract][Full Text] [Related]
29. Telmisartan acts through the modulation of ACE-2/ANG 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Life Sci; 2012 Feb; 90(7-8):289-300. PubMed ID: 22210452
[TBL] [Abstract][Full Text] [Related]
30. Recombinant Human ACE2 and the Angiotensin 1-7 Axis as Potential New Therapies for Heart Failure.
Patel VB; Lezutekong JN; Chen X; Oudit GY
Can J Cardiol; 2017 Jul; 33(7):943-946. PubMed ID: 28279521
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Angiotensin-Converting Enzyme 2 Ameliorates Amyloid β-Induced Inflammatory Response in Human Primary Retinal Pigment Epithelium.
Fu X; Lin R; Qiu Y; Yu P; Lei B
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3018-3028. PubMed ID: 28605813
[TBL] [Abstract][Full Text] [Related]
32. [Effect of Chinese herbs for stasis removing and collaterals dredging upon angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis in the renal cortex of diabetic nephropathy rats].
Xu J; Ma EW; Bai L; Ma Y; Guo Q; Jia R; Zhang JH; Chen ZQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):714-21. PubMed ID: 25046956
[TBL] [Abstract][Full Text] [Related]
33. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
34. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats.
Joyner J; Neves LA; Granger JP; Alexander BT; Merrill DC; Chappell MC; Ferrario CM; Davis WP; Brosnihan KB
Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R169-77. PubMed ID: 17428896
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
36. Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury.
Shao Y; He M; Zhou L; Yao T; Huang Y; Lu LM
Acta Pharmacol Sin; 2008 Jul; 29(7):829-37. PubMed ID: 18565281
[TBL] [Abstract][Full Text] [Related]
37. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.
Giani JF; Miquet JG; Muñoz MC; Burghi V; Toblli JE; Masternak MM; Kopchick JJ; Bartke A; Turyn D; Dominici FP
Growth Horm IGF Res; 2012 Dec; 22(6):224-33. PubMed ID: 22947377
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
